| Hyperthermic intraperitoneal chemotherapy in ovarian cancer WJ Van Driel, SN Koole, K Sikorska, JH Schagen van Leeuwen, ... New England Journal of Medicine 378 (3), 230-240, 2018 | 549 | 2018 |
| Type I and II endometrial cancers: have they different risk factors? VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ... Journal of Clinical Oncology 31 (20), 2607, 2013 | 510 | 2013 |
| Assessing tumor infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311, 2017 | 324 | 2017 |
| Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ... The Journal of pathology 223 (1), 72-80, 2011 | 242 | 2011 |
| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 162 | 2019 |
| Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group C Denkert, S Wienert, A Poterie, S Loibl, J Budczies, S Badve, ... Modern Pathology 29 (10), 1155-1164, 2016 | 127 | 2016 |
| The histophysiology and pathophysiology of the peritoneum J Van Baal, KK Van de Vijver, R Nieuwland, CJF Van Noorden, ... Tissue and Cell 49 (1), 95-105, 2017 | 94 | 2017 |
| A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer RD Brandão, J Veeck, KK Van de Vijver, P Lindsey, B De Vries, ... Breast Cancer Research 15 (2), R29, 2013 | 83 | 2013 |
| Expression of aberrantly glycosylated Mucin‐1 in ovarian cancer CHMJ Van Elssen, PWH Frings, FJ Bot, KK Van de Vijver, MB Huls, ... Histopathology 57 (4), 597-606, 2010 | 74 | 2010 |
| Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol KMC Cornel, RFPM Kruitwagen, B Delvoux, L Visconti, KK Van de Vijver, ... The Journal of Clinical Endocrinology & Metabolism 97 (4), E591-E601, 2012 | 59 | 2012 |
| L1CAM expression in endometrial carcinomas: an ENITEC collaboration study LJM Van Der Putten, NCM Visser, K Van De Vijver, M Santacana, ... British journal of cancer 115 (6), 716-724, 2016 | 57 | 2016 |
| LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation KK Van de Vijver, AM Deelder, W Jacobs, EA Van Marck, CH Hokke Glycobiology 16 (3), 237-243, 2006 | 56 | 2006 |
| The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07) LM Van Roozendaal, JHW de Wilt, T Van Dalen, JA Van der Hage, ... BMC cancer 15 (1), 1-8, 2015 | 53 | 2015 |
| Difficulties with diagnosis of malignancies in pregnancy J de Haan, V Vandecaveye, SN Han, KK Van de Vijver, F Amant Best Practice & Research Clinical Obstetrics & Gynaecology 33, 19-32, 2016 | 50 | 2016 |
| No improvement in long-term survival for epithelial ovarian cancer patients: a population-based study between 1989 and 2014 in the Netherlands M Timmermans, GS Sonke, KK Van de Vijver, MA Van der Aa, ... European Journal of Cancer 88, 31-37, 2018 | 46 | 2018 |
| Glycans of Schistosoma mansoni and keyhole limpet haemocyanin induce hepatic granulomas in vivo KK Van de Vijver, CH Hokke, A van Remoortere, W Jacobs, AM Deelder, ... International journal for parasitology 34 (8), 951-961, 2004 | 44 | 2004 |
| Diagnostic performance of dedicated axillary T2-and diffusion-weighted MR imaging for nodal staging in breast cancer RJ Schipper, ML Paiman, RGH Beets-Tan, PJ Nelemans, B de Vries, ... Radiology 275 (2), 345-355, 2015 | 40 | 2015 |
| E2Fs mediate a fundamental cell‐cycle deregulation in high‐grade serous ovarian carcinomas T De Meyer, ITGW Bijsmans, KK Van de Vijver, S Bekaert, J Oosting, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 40 | 2009 |
| Mucinous borderline tumours of the ovary and the appendix: a retrospective study and overview of the literature M Kleppe, J Bruls, T Van Gorp, L Massuger, BFM Slangen, ... Gynecologic oncology 133 (2), 155-158, 2014 | 37 | 2014 |
| Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival M Sobral-Leite, K Van de Vijver, M Michaut, R van der Linden, ... Oncoimmunology 7 (12), e1509820, 2018 | 36 | 2018 |
Toon Van GorpProfessor of Gynaecological Oncology @ University of LeuvenVerified email at uzleuven.be
